Marianna Kulka

Nanotechnology Research Center, National Research Council Canada

Affiliated withNational Research Council Canada University of Alberta

Research Area

Bioengineering

Biography

Marianna Kulka has not added Biography.
If you are Marianna Kulka and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

Article Total : 1	Year
Publication title	2021

Other Publications

Article	Year
Neuropeptides activate human mast cell degranulation and chemokine production. Immunology\| PubMed ID: 17922833	2008
Isolation of tissue mast cells. Current protocols in immunology\| PubMed ID: 18432836	2001
Substance P downregulates expression of the high affinity IgE receptor (FcepsilonRI) by human mast cells. Journal of neuroimmunology\| PubMed ID: 20117843	2010
Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2. Immunology\| PubMed ID: 20497485	2010
Isolation of tissue mast cells. Current protocols in immunology / edited by John E. Coligan ... [et al.]\| PubMed ID: 20814941	2010
Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature\| PubMed ID: 25517090	2015
n-3 Polyunsaturated fatty acids and mast cell activation. Journal of leukocyte biology\| PubMed ID: 25765678	2015
The Novel Receptor C5aR2 Is Required for C5a-Mediated Human Mast Cell Adhesion, Migration, and Proinflammatory Mediator Production. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 26283482	2015
n-3 Polyunsaturated fatty acids inhibit Fc ε receptor I-mediated mast cell activation. The Journal of nutritional biochemistry\| PubMed ID: 26363927	2015
Cross-talk between human mast cells and epithelial cells by IgE-mediated periostin production in eosinophilic nasal polyps. The Journal of allergy and clinical immunology\| PubMed ID: 27771323	2017
Could substance P be an antiviral mediator and potential therapeutic target in the nose? The Journal of allergy and clinical immunology\| PubMed ID: 29146273	2018
Lipofection of plasmid DNA into human mast cell lines using lipid nanoparticles generated by microfluidic mixing. Journal of leukocyte biology\| PubMed ID: 29668121	2018
Bicyclic eremophilane-type petasite sesquiterpenes potentiate peroxisome proliferator-activated receptor γ activator-mediated inhibition of dendritic cells. International journal of immunopathology and pharmacology\| PubMed ID: 30014756	2018
Adenosine activates Gα proteins and inhibits C3a-induced activation of human mast cells. Biochemical pharmacology\| PubMed ID: 30099007	2018
The Possible Uses and Challenges of Nanomaterials in Mast Cell Research. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 32253270	2020
Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system. European journal of neurology\| PubMed ID: 32668062	2020
A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis. Biochemistry and cell biology = Biochimie et biologie cellulaire\| PubMed ID: 33027600	2021
Disrupted Lipid Raft Shuttling of FcεRI by n-3 Polyunsaturated Fatty Acid Is Associated With Ligation of G Protein-Coupled Receptor 120 (GPR120) in Human Mast Cell Line LAD2. Frontiers in nutrition\| PubMed ID: 33330598	2020
Harnessing the Power of Mast Cells in unconventional Immunotherapy Strategies and Vaccine Adjuvants. Cells\| PubMed ID: 33352850	2020
Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases. International journal of molecular sciences\| PubMed ID: 33499208	2021
Sesquiterpene-Loaded Co-Polymer Hybrid Nanoparticle Effects on Human Mast Cell Surface Receptor Expression, Granule Contents, and Degranulation. Nanomaterials (Basel, Switzerland)\| PubMed ID: 33917960	2021